AI in Drug Design
Regina discusses the transformative potential of AI in healthcare, particularly in drug design. She highlights the current limitations in drug development using machine learning and emphasizes the exciting opportunities for innovation in molecule generation and screening. The conversation delves into the technical aspects of representing small molecules as graphs and the importance of high-throughput screening in identifying effective compounds.In this clip
From this podcast
Lex Fridman Podcast
Regina Barzilay: Deep Learning for Cancer Diagnosis and Treatment | Lex Fridman Podcast #40
Related Questions